Combination Drug Therapy

Healio spoke with Philip J. Mease, MD, about ongoing research in psoriatic arthritis.

MIAMI BEACH, Fla. — Adults with binge-eating disorder who were given acute naltrexone/bupropion performed better with similar maintenance treatment compared with placebo, per data from the American Society of Clinical Psychopharmacology annual meeting.

CuraSen Therapeutics Inc. announced positive data from its randomized, double-blind crossover phase 2 study of CST-103/CST-107, which demonstrated improvements in cognition and mood in those with Parkinson’s disease.

This year, Rosacea Awareness Month focuses on the importance of consistency and patience when trying new rosacea therapies, according to the National Rosacea Society.

Visus Therapeutics completed enrollment in a pivotal phase 3 trial investigating Brimochol PF for the treatment of presbyopia.

A combination therapy of IV doxycycline and azithromycin was more effective for the treatment of severe scrub typhus than using either drug alone, according to findings published Wednesday in The New England Journal of Medicine.

The 2023 Global Initiative for Chronic Obstructive Lung Disease report defines several changes regarding definitions, assessment tools and treatments for COPD, all of which underscore recent advances in the field.

Megan Kruse, MD, a breast medical oncologist at Cleveland Clinic, spoke with Healio about results from her research on real-world sequential and non-sequential use of CDK4/6 inhibitors in a subset of breast cancer patients.

AMELIA ISLAND, Fla. — In this video from Cataract Surgery: Telling It Like It Is, Richard L. Lindstrom, MD, discusses the utility of compounded pharmaceuticals in treating dry eye disease.

Three large professional thyroid organizations issued a joint statement calling for new trials of combination therapy to treat hypothyroidism, citing new clinical endpoints and the importance of assessing patient-reported outcomes.